Literature DB >> 3272195

Determinants of late survival of 105 patients operated for dissection of the aorta.

G Rizzoli1, L Gregio, A Mazzucco, P Stritoni, A Fracasso, T Brumana, V Gallucci.   

Abstract

In the surgery of aortic dissection, only a small section of aorta compared to the extent of the aortic damage, is usually replaced. The disease is not cured by surgery and needs continuous postoperative surveillance and medical therapy. We report the follow-up of 105 patients who were operated upon between January 1970 and April 1986 and discharged from hospital. Overall actuarial survival was 90% at 5 years, 52% at 10 years and 39% at 15 years. There were 20 deaths, mostly (85%) related to cardiovascular causes. Survival times were correlated, using multivariate methods, with several pre-, peri- and postoperative variables to identify significant risk factors and to calculate actuarial survivals. We found that postoperative low output syndrome (p = 0.007) and stroke (p = 0.04) adversely affected survival and that previous aortic disease or operation (p = 0.004) was associated with an increased rate of dissection-related complications. On the contrary, preoperative hypertension was related to a significantly better survival (p = 0.01) and survival free of dissection-related complications (p = 0.001). When dissection was related to hypertension, adequate postoperative medical treatment neutralized the progression of the aortic damage and its consequences. When dissection was not due to hypertension, the observed survival was unsatisfactory, probably because of a more fragile aorta and inadequate medical follow-up therapy.

Entities:  

Mesh:

Year:  1988        PMID: 3272195     DOI: 10.1016/1010-7940(88)90091-7

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  2 in total

1.  Management and long-term outcome of aortic dissection.

Authors:  D D Glower; R H Speier; W D White; L R Smith; J S Rankin; W G Wolfe
Journal:  Ann Surg       Date:  1991-07       Impact factor: 12.969

2.  Niclosamide encapsulated polymeric nanocarriers for targeted cancer therapy.

Authors:  Nishant Kumar Jain; Prabhuraj R S; M C Bavya; Rajendra Prasad; Rajdip Bandyopadhyaya; V G M Naidu; Rohit Srivastava
Journal:  RSC Adv       Date:  2019-08-27       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.